VT News
Esteban González Pons

Esteban González Pons

Ask VT AI
View News Summary
  • Vinay Prasad, the FDA's Biologics head, was reinstated after facing pressure from right-wing activists and criticism over his handling of a gene therapy drug.
  • Fundamentally strong stocks face temporary challenges but maintain long-term growth prospects, while more volatile and struggling companies raise investor concerns.
  • Asian shares rise ahead of critical US tariff deadline and key inflation data, as investors await Fed's next move amid growth and recession concerns.
5 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Vinay Prasad, the FDA's Biologics head, was reinstated after facing pressure from right-wing activists and criticism over his handling of a gene therapy drug.
  • Fundamentally strong stocks face temporary challenges but maintain long-term growth prospects, while more volatile and struggling companies raise investor concerns.
  • Asian shares rise ahead of critical US tariff deadline and key inflation data, as investors await Fed's next move amid growth and recession concerns.
5 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Esteban González Pons

Top Topics

Trending in U.S.

World

Sport